NCT06369272View on ClinicalTrials.gov

Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy

CompletedOBSERVATIONAL

Enrollment

1,192

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

October 20, 2023

Study Completion Date

October 20, 2023

Conditions

Maternal OutcomesInfant OutcomesPregnancy

Trial Locations (1)

02458

Carelon Research, Newton

All Listed Sponsors

lead

ModernaTX, Inc.

INDUSTRY